IS YOUR CHINESE PATENT TRANSLATION FILING-READY?
Learn what makes a Chinese patent translation filing-ready for CNIPA, from terminology consistency and claim accuracy to specialist human review.
Silvia Pedraza
WHY MEMES NEED TRANSCREATION, NOT TRANSLATION
Your message can be flawless and still fall flat abroad. A study on 6,000+ US and Chinese memes shows why, and how transcreation fixes it.
THE LINGUISTIC DUE DILIGENCE CHECKLIST FOR CROSS-BORDER M&A
A mistranslated clause can unravel a cross-border deal after closing. Here’s what linguistic due diligence is, and the 5-point checklist to run before signing.
BUSINESS LOCALIZATION: CHOOSING THE RIGHT LANGUAGES
A practical framework for prioritizing languages by market potential, buyer behavior, and ROI. For decision-makers planning global growth.
WHY APPROVED TEXT FAILS IN NEW SUBMISSIONS
One copied sentence can delay a regulatory launch. Here’s why approved wording can become a compliance risk in a new context.
THE HUMAN GENOME: HOW LANGUAGE SHAPES THE FUTURE OF BIOTECH IP
In genomics IP, a mistranslated claim can cost hundreds of millions. Here’s what the Human Genome Project taught us about language, patents, and legal consequences.
WHAT STAGNANT LANGUAGE COSTS A GROWING BUSINESS
Your business evolved. Did your messaging? Discover how outdated language creates friction and why translation and localization belong in your growth strategy.
WHAT THE 2026 IP LAW CHANGES MEAN FOR PATENT TRANSLATION
A compliant patent can still face objection if its translation falls short. Here’s what the 2026 IP law changes imply for cross-border filings and language services.
WHY SECTOR FLUENCY IS BECOMING A STRATEGIC BUDGET DECISION
Why the lowest translation rate may cost you more. Discover how sector fluency reduces internal effort in regulated industries.
FROM REWRITING TO APPROVING: HOW TO CUT MLR REVIEW CYCLES
Cut internal review cycles in pharma and medtech. Discover how submission-ready translation reduces MLR friction and launch delays.